
Cardiotoxicity in Cancer Patients: What You Should Know
Cardiotoxicity is an alteration in the function of the heart muscle caused by certain cancer treatments, especially antineoplastic drugs such as anthracyclines. This dysfunction can progress to heart failure, one of the most serious complications in cancer patients. In the early stages, we speak of subclinical or preclinical cardiotoxicity, when







